Subscribe
The AI leader’s shares have been flat since the summer despite continued growth
Global data centre capacity is projected to double by 2030
The medical equipment manufacturer has been ailing, but its condition should stabilise
The building materials group is to decide on whether to delist UK shares by the end of March
The Big Australian’s first half saw copper profits overtake iron ore for the first time
The Squeeze: Focusing on a single issue can blind investors in the long term
Activist who campaigned for Honeywell’s break-up expects its parts to be worth much more than its whole
The company’s turnaround progress is slow but will reward patient investors
The company’s strong performance came while its fast food rivals have struggled
Pharma’s AI investment fits far better into the industry’s business model